Promising Potential for Prostate and Bladder Tumor: Reprogra

Research indicates a new drug reprograms the macrophage immune cells, offering hope for prostate and bladder cancer patients.

Related Keywords

United States , American , Jonathan Powell , Johns Hopkins , Roberte Meyerhoff , Jelani Zarif , Barbara Slusher , Cancer Immunology Research , Bloomberg Kimmel Institute For Cancer Immunotherapy , American Association For Cancer Research , Johns Hopkins University , Johns Hopkins Kimmel Cancer Center , Kimmel Institute , Johns Hopkins Drug , American Association , Endowed Professor , Glutamine Blocking Drug Zarif , Johns Hopkins Drug Discovery ,